Vice President of Clinical Pharmacology
Third Arc Bio
Dr. Michael Z. Liao, Ph.D. MLS (Mike) is currently the Vice President of Clinical Pharmacology of Third Arc Bio and Affiliate Associate Professor of the University of Washington School of Pharmacy. Prior to Third Arc Bio, Mike was at the Clinical Pharmacology department at Genentech, led ADC and Bispecific antibody development. He contributed to the global approval of POLIVY® in Previously Untreated and in Relapsed/Refractory DLBCL. Before Genentech, Mike led the clinical pharmacology development of tarlatamab, acapatamab, IMLYGIC, and Vectibix at Amgen. Earlier in his career, Mike’s ORISE fellowship at the US FDA provided him with invaluable regulatory and MIDD insights, which he continues to apply to innovative drug development. Michael earned his B.S. in Laboratory Medicine and Ph.D. in Pharmaceutics from the University of Washington. Mike has 30+ peer reviewed publications. He was selected for the ASCPT Leadership Accelerator and has cofounded the CGRN community, as well as chaired the ASCPT EDDS and the CGRN community.
Cell and Gene Therapy: Transforming Treatment Paradigms for Patient-Centric Care
Friday, April 4, 2025
10:00 AM - 2:00 PM East Coast USA Time
Poster Walk II: Innovations in DMPK and Clinical Pharmacology
Thursday, May 29, 2025
5:55 PM - 6:25 PM East Coast USA Time